979f EFFICACY AND SAFETY OF THE FIRST CO-ANTIBODY THERAPY, JNJ-78934804, IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE REFRACTORY TO SYSTEMIC THERAPIES
1. 请及时下载文件确认是否正确, 系统将在 2026-11-28 12:29:45 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S0016-5085(26)06752-1
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0016508526067521
其他信息:
出版社: Elsevier BV
作者: Bruce E. Sands; Geert D’Haens; Iris Dotan; Natalie A. Terry; Monica Walker; Vanessa Bundy; Hayley Perry; Marion Vetter; Taku Kobayashi; Stefan Schreiber; Vipul Jairath

